Stay updated on HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial

Sign up to get notified when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision tag updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:34:29.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-19T22:10:30.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:14:01.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page shows an updated revision label: v3.4.2 replaces the previous v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T02:08:58.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    A minor revision tag was updated from v3.4.0 to v3.4.1 on the page, with no changes to study content or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T00:28:57.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    UI/content updates include showing the glossary toggle and updating header/footer/version text: added 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while the corresponding lowercased items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T21:43:54.000Z thumbnail image

Stay in the know with updates to HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.